Reyvow

Generic name: Lasmiditan
Drug class: Antimigraine agents

Usage of Reyvow

Reyvow is a serotonin (5-HT) 1F receptor agonist.

Reyvow is used in adults to treat migraine headaches with or without aura.

Reyvow will only treat and will not prevent migraine headache.

Reyvow side effects

Get emergency medical help if you have signs of an allergic reaction to Reyvow: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Seek medical attention right away if you have symptoms of serotonin syndrome, such as: agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness, twitching, loss of coordination, nausea, vomiting, or diarrhea.

Common Reyvow side effects may include:

dizziness, drowsiness;

feeling tired; or

numbness or tingling.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Reyvow

To make sure Reyvow is safe for you, tell your doctor if you have:

an allergy to lasmiditan;

liver disease;

slow heartbeats;

high blood pressure; or

drug addiction.

Be sure your doctor knows if you also take stimulant medicine, opioid medicine, herbal products, or medicine for depression, mental illness, Parkinson's disease, migraine headaches, serious infections, or prevention of nausea and vomiting. These medicines may interact with lasmiditan and cause a serious condition called serotonin syndrome.

If you are pregnant, your name may be listed on a pregnancy registry to track the effects of lasmiditan on the baby.

Tell your doctor if you are pregnant or plan to become pregnant. It is not known whether lasmiditan will harm an unborn baby. However, having migraine headaches during pregnancy may cause complications such as eclampsia (dangerously high blood pressure that can lead to medical problems in both mother and baby). The benefit of treating migraines may outweigh any risks to the baby.

It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.

Relate drugs

How to use Reyvow

Usual Adult Dose for Migraine:

Initial dose: 50 mg, 100 mg, or 200 mg orally once Maximum dose: 1 dose per day Comments: -This drug should not be taken unless the patient can wait 8 hours or more before driving or operating machinery. -No more than 1 dose should be taken in 24 hours; a second dose has not been shown to be effective for the same migraine attack. -The safety of treating an average of more than 4 migraine attacks in a 30-day period has not been established. -This drug is not indicated for the prevention of migraine attacks. Use: For the acute treatment of migraine with or without aura.

Warnings

Reyvow is a federally controlled substance (CV) because it contains lasmiditan that can be a target for people who abuse prescription medicines or street drugs.

Keep this medicine in a safe place to protect it from theft. Never give your Reyvow to anyone else, because it may harm them. Selling or giving away Reyvow is against the law. Tell your healthcare provider if you have ever abused or been dependent on alcohol, prescription medicines or street drugs.

Do not take more than one dose in a 24-hour period.

For at least 8 hours after taking Reyvow, do not drive and avoid other hazardous activity.

What other drugs will affect Reyvow

Using Reyvow with other drugs that make you drowsy can worsen this effect. Ask your doctor before using opioid medication, a sleeping pill, a muscle relaxer, or medicine for anxiety or seizures.

Many drugs may interact with lasmiditan. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any medicine you start or stop using.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.